-
1
-
-
0342368756
-
New combinations in the treatment of lung cancer: a time for optimism
-
Bunn Jr. P.A., and Kelly K. New combinations in the treatment of lung cancer: a time for optimism. Chest 117 (2000) 138S-143S
-
(2000)
Chest
, vol.117
-
-
Bunn Jr., P.A.1
Kelly, K.2
-
2
-
-
0028843552
-
Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials
-
Non Small Cell Lung Cancer Collaborative Group
-
Non Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311 (1995) 899-909
-
(1995)
BMJ
, vol.311
, pp. 899-909
-
-
-
3
-
-
0037106514
-
Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why?
-
Bunn Jr. P.A. Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why?. J Clin Oncol 20 (2002) 23S-33S
-
(2002)
J Clin Oncol
, vol.20
-
-
Bunn Jr., P.A.1
-
4
-
-
0037050352
-
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
-
Schiller J.H., Harrington D., Belani C.P., et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346 (2002) 92-98
-
(2002)
N Engl J Med
, vol.346
, pp. 92-98
-
-
Schiller, J.H.1
Harrington, D.2
Belani, C.P.3
-
5
-
-
0035397994
-
Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial
-
Kelly K., Crowley J., Bunn Jr. P.A., et al. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol 19 (2001) 3210-3218
-
(2001)
J Clin Oncol
, vol.19
, pp. 3210-3218
-
-
Kelly, K.1
Crowley, J.2
Bunn Jr., P.A.3
-
6
-
-
0030912190
-
Revisions in the international system for staging lung cancer
-
Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
-
(1997)
Chest
, vol.111
, pp. 1710-1717
-
-
Mountain, C.F.1
-
7
-
-
0028070358
-
Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telophase
-
Long B.H., and Fairchild C.R. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telophase. Cancer Res 54 (1994) 4355-4361
-
(1994)
Cancer Res
, vol.54
, pp. 4355-4361
-
-
Long, B.H.1
Fairchild, C.R.2
-
8
-
-
0029745777
-
Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel
-
Milross C.G., Mason K.A., Hunter N.R., et al. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst 88 (1996) 1308-1314
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1308-1314
-
-
Milross, C.G.1
Mason, K.A.2
Hunter, N.R.3
-
9
-
-
0036135980
-
Mutational analysis of the beta-tubulin gene in lung cancer
-
Tsurutani J., Komiya T., Uejima H., et al. Mutational analysis of the beta-tubulin gene in lung cancer. Lung Cancer 35 (2002) 11-16
-
(2002)
Lung Cancer
, vol.35
, pp. 11-16
-
-
Tsurutani, J.1
Komiya, T.2
Uejima, H.3
-
10
-
-
0029417238
-
Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vitro
-
Anne B., Heldi A.L., Pierre D., et al. Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vitro. Cell 83 (1995) 1159-1169
-
(1995)
Cell
, vol.83
, pp. 1159-1169
-
-
Anne, B.1
Heldi, A.L.2
Pierre, D.3
-
11
-
-
0034682703
-
Motor function in the mitotic spindle
-
Heald R. Motor function in the mitotic spindle. Cell 102 (2000) 399-402
-
(2000)
Cell
, vol.102
, pp. 399-402
-
-
Heald, R.1
-
12
-
-
0033615357
-
Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen
-
Mayer T.U., Kapoor T.M., Haggarty S.J., et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286 (1999) 971-974
-
(1999)
Science
, vol.286
, pp. 971-974
-
-
Mayer, T.U.1
Kapoor, T.M.2
Haggarty, S.J.3
-
13
-
-
10744220712
-
Inhibition of a mitotic motor protein: where, how, and conformational consequences
-
Youwei Y., Vinod S., Bei X., et al. Inhibition of a mitotic motor protein: where, how, and conformational consequences. J Mol Biol 335 (2004) 547-554
-
(2004)
J Mol Biol
, vol.335
, pp. 547-554
-
-
Youwei, Y.1
Vinod, S.2
Bei, X.3
-
14
-
-
0034605123
-
Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5
-
Kapoor T.M., Mayer T.U., Coughlin M.L., et al. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5. J Cell Biol 150 (2000) 975-988
-
(2000)
J Cell Biol
, vol.150
, pp. 975-988
-
-
Kapoor, T.M.1
Mayer, T.U.2
Coughlin, M.L.3
-
15
-
-
0028148191
-
The cyclin-dependent protein kinases and the control of cell division
-
Doree M., and Garas S. The cyclin-dependent protein kinases and the control of cell division. FASEB J 8 (1994) 1114-1121
-
(1994)
FASEB J
, vol.8
, pp. 1114-1121
-
-
Doree, M.1
Garas, S.2
-
16
-
-
0036604222
-
Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma
-
Takeno S., Noguchi T., Kikuchi R., et al. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer 94 (2002) 2874-2881
-
(2002)
Cancer
, vol.94
, pp. 2874-2881
-
-
Takeno, S.1
Noguchi, T.2
Kikuchi, R.3
-
17
-
-
0034890565
-
Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue
-
Hassan K.A., El-Nagaar A.K., Soria J.C., et al. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res 7 (2001) 2458-2462
-
(2001)
Clin Cancer Res
, vol.7
, pp. 2458-2462
-
-
Hassan, K.A.1
El-Nagaar, A.K.2
Soria, J.C.3
-
18
-
-
0033870724
-
Overexpression of cyclin B1 in early stage non-small cell lung cancer and its clinical implication
-
Soria J.C., Jang S.J., Khuri F.R., et al. Overexpression of cyclin B1 in early stage non-small cell lung cancer and its clinical implication. Cancer Res 60 (2000) 4000-4004
-
(2000)
Cancer Res
, vol.60
, pp. 4000-4004
-
-
Soria, J.C.1
Jang, S.J.2
Khuri, F.R.3
-
19
-
-
0030912190
-
Revisions in the international system for staging lung cancer
-
Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
-
(1997)
Chest
, vol.111
, pp. 1710-1717
-
-
Mountain, C.F.1
-
20
-
-
0342368756
-
New combinations in the treatment of lung cancer: a time for optimism
-
Bunn Jr. P.A., and Kelly K. New combinations in the treatment of lung cancer: a time for optimism. Chest 117 (2000) 138S-143S
-
(2000)
Chest
, vol.117
-
-
Bunn Jr., P.A.1
Kelly, K.2
-
21
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors
-
Patrick T., Susan G.A., Elizabeth A.E., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 (2000) 205-216
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 205-216
-
-
Patrick, T.1
Susan, G.A.2
Elizabeth, A.E.3
-
22
-
-
12144287061
-
Breast cancer resistant protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer
-
Yoh K., Ishii G., Yokose T., et al. Breast cancer resistant protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Clin Cancer Res 10 (2004) 1691-1697
-
(2004)
Clin Cancer Res
, vol.10
, pp. 1691-1697
-
-
Yoh, K.1
Ishii, G.2
Yokose, T.3
-
23
-
-
8444240380
-
Dominant papillary subtype is a significant predictor of the response to gefitinib in adenocarcinoma of the lung
-
Kim Y.H., Ishii G., Goto K., et al. Dominant papillary subtype is a significant predictor of the response to gefitinib in adenocarcinoma of the lung. Clin Cancer Res 10 (2004) 7311-7317
-
(2004)
Clin Cancer Res
, vol.10
, pp. 7311-7317
-
-
Kim, Y.H.1
Ishii, G.2
Goto, K.3
-
24
-
-
2342618971
-
Monastrol, a prototype anti-cancer drug that inhibits a mitotic kinesin, induces rapid bursts of axonal outgrowth from cultured post mitotic neurons
-
Haque S.A., Hasaka T.P., Brooks A.D., et al. Monastrol, a prototype anti-cancer drug that inhibits a mitotic kinesin, induces rapid bursts of axonal outgrowth from cultured post mitotic neurons. Cell Motil Cytoskel 58 (2004) 10-16
-
(2004)
Cell Motil Cytoskel
, vol.58
, pp. 10-16
-
-
Haque, S.A.1
Hasaka, T.P.2
Brooks, A.D.3
-
25
-
-
0032525308
-
Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint
-
Toyoshima F., Moriguchi T., Wada A., et al. Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint. EMBO J 17 (1998) 2728-2735
-
(1998)
EMBO J
, vol.17
, pp. 2728-2735
-
-
Toyoshima, F.1
Moriguchi, T.2
Wada, A.3
-
26
-
-
0027933911
-
The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B
-
Pines J., and Hunter T. The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B. EMBO J 13 (1994) 3772-3781
-
(1994)
EMBO J
, vol.13
, pp. 3772-3781
-
-
Pines, J.1
Hunter, T.2
-
27
-
-
15744404844
-
Mitotic kinesin inhibitors induce mitotic arrest and cell death in taxol-resistant and -sensitive cancer cells
-
Marcus A.I., Peters U., Thomas S.L., et al. Mitotic kinesin inhibitors induce mitotic arrest and cell death in taxol-resistant and -sensitive cancer cells. J Biol Chem 280 (2005) 11569-11577
-
(2005)
J Biol Chem
, vol.280
, pp. 11569-11577
-
-
Marcus, A.I.1
Peters, U.2
Thomas, S.L.3
-
28
-
-
4344595410
-
Differential effects of monastrol in two human cell lines
-
Leizerman I., Avunie-Masala R., Elkabets M., et al. Differential effects of monastrol in two human cell lines. Cell Mol Life Sci 61 (2004) 2060-2070
-
(2004)
Cell Mol Life Sci
, vol.61
, pp. 2060-2070
-
-
Leizerman, I.1
Avunie-Masala, R.2
Elkabets, M.3
-
29
-
-
2342563857
-
Antitumor activity of kinesin inhibitor
-
Roman S., Jeffery T.F., Christophe B., et al. Antitumor activity of kinesin inhibitor. Cancer Res 64 (2004) 3276-3280
-
(2004)
Cancer Res
, vol.64
, pp. 3276-3280
-
-
Roman, S.1
Jeffery, T.F.2
Christophe, B.3
-
30
-
-
1842527037
-
Transient exposure to the Eg5 kinesin inhibitor monastrol leads to syntelic orientation of chromosomes and aneuroploidy in mouse oocytes
-
John B.M., Colette M., and John W.F. Transient exposure to the Eg5 kinesin inhibitor monastrol leads to syntelic orientation of chromosomes and aneuroploidy in mouse oocytes. Mutat Res 559 (2004) 153-167
-
(2004)
Mutat Res
, vol.559
, pp. 153-167
-
-
John, B.M.1
Colette, M.2
John, W.F.3
-
31
-
-
0036752261
-
Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5
-
Maliga Z., Kapoor T.M., and Mitchinson T.J. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5. Chem Biol 9 (2002) 989-996
-
(2002)
Chem Biol
, vol.9
, pp. 989-996
-
-
Maliga, Z.1
Kapoor, T.M.2
Mitchinson, T.J.3
-
32
-
-
0034605123
-
Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin Eg5
-
Kapoor T.M., Mayer T.U., Coughlin M.L., et al. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin Eg5. J Cell Biol 150 (2000) 975-988
-
(2000)
J Cell Biol
, vol.150
, pp. 975-988
-
-
Kapoor, T.M.1
Mayer, T.U.2
Coughlin, M.L.3
|